Literature DB >> 18617693

Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis.

Mélanie Eyries1, Géraldine Siegfried, Mariana Ciumas, Kevin Montagne, Monique Agrapart, Franck Lebrin, Florent Soubrier.   

Abstract

Apelin has been identified as the endogenous ligand of the human orphan G protein-coupled receptor APJ. This peptide exerts a variety of cardiovascular effects and particularly acts as an activator of angiogenesis. Importantly, hypoxia has been reported to regulate apelin expression but the molecular mechanism underlying hypoxia-induced apelin expression and the relationship with the physiological response of the apelin/APJ system are still not established. Here, we demonstrate that apelin expression is induced by hypoxia in cultured endothelial and vascular smooth muscle cells as well as in lung from mice exposed to acute hypoxia. Transient transfection experiments show that hypoxia-inducible transcriptional activation of apelin requires an intact hypoxia-responsive element (+813/+826) located within the first intron of the human apelin gene. Chromatin immunoprecipitation assay reveals that hypoxia-inducible factor-1alpha binds to the endogenous hypoxia-responsive element site of the apelin gene. Moreover, overexpression of hypoxia-inducible factor-1alpha increases the transcriptional activity of a reporter construct containing this hypoxia-responsive element, whereas small interfering RNA-mediated hypoxia-inducible factor-1alpha knockdown abolishes hypoxia-induced apelin expression. Finally, microinterfering RNA-mediated apelin or APJ receptor knockdown inhibits both hypoxia-induced endothelial cell proliferation in vitro and hypoxia-induced vessel regeneration in the caudal fin regeneration of Fli-1 transgenic zebrafish. The hypoxia-induced apelin expression may, thus, provide a new mechanism involved in adaptive physiological and pathophysiological response of vascular cells to low oxygen level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617693     DOI: 10.1161/CIRCRESAHA.108.179333

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  82 in total

1.  Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction.

Authors:  Florence Tatin; Edith Renaud-Gabardos; Anne-Claire Godet; Fransky Hantelys; Francoise Pujol; Florent Morfoisse; Denis Calise; Fanny Viars; Philippe Valet; Bernard Masri; Anne-Catherine Prats; Barbara Garmy-Susini
Journal:  JCI Insight       Date:  2017-06-15

Review 2.  The exercising heart at altitude.

Authors:  José A L Calbet; Paul Robach; Carsten Lundby
Journal:  Cell Mol Life Sci       Date:  2009-10-07       Impact factor: 9.261

3.  ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease.

Authors:  Christopher Lathen; Yu Zhang; Jennifer Chow; Martanday Singh; Grace Lin; Vishal Nigam; Yasser A Ashraf; Jason X Yuan; Ivan M Robbins; Patricia A Thistlethwaite
Journal:  Circulation       Date:  2014-07-25       Impact factor: 29.690

4.  IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle.

Authors:  Mac B Robinson; Deepak A Deshpande; Jeffery Chou; Wei Cui; Shelly Smith; Carl Langefeld; Annette T Hastie; Eugene R Bleecker; Gregory A Hawkins
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

5.  Genetic differences and aberrant methylation in the apelin system predict the risk of high-altitude pulmonary edema.

Authors:  Aastha Mishra; Samantha Kohli; Sanchi Dua; Tashi Thinlas; Ghulam Mohammad; M A Qadar Pasha
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

6.  Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation.

Authors:  Terika P Smith; Alyssa M Schlenz; Jeffrey C Schatz; Rangan Maitra; Sarah M Sweitzer
Journal:  Blood Cells Mol Dis       Date:  2014-11-26       Impact factor: 3.039

7.  Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.

Authors:  Manuela Cabiati; Melania Gaggini; Paolo De Simone; Silvia Del Ry
Journal:  Clin Exp Med       Date:  2020-11-17       Impact factor: 3.984

8.  Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation.

Authors:  Antonio Lacquaniti; Giuseppe Altavilla; Antonio Picone; Valentina Donato; Valeria Chirico; Patrizia Mondello; Carmela Aloisi; Grazia Marabello; Saverio Loddo; Antoine Buemi; Giuseppina Lorenzano; Michele Buemi
Journal:  Clin Exp Med       Date:  2014-01-28       Impact factor: 3.984

9.  Zebrafish ProVEGF-C expression, proteolytic processing and inhibitory effect of unprocessed ProVEGF-C during fin regeneration.

Authors:  Abdel-Majid Khatib; Rachid Lahlil; Nathalie Scamuffa; Marie-Andrée Akimenko; Sylvain Ernest; Abdderahim Lomri; Claude Lalou; Nabil G Seidah; Bruno O Villoutreix; Fabien Calvo; Geraldine Siegfried
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.

Authors:  Mark Slevin; Jerzy Krupinski; Lina Badimon
Journal:  J Angiogenes Res       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.